| Name | Title | Contact Details |
|---|---|---|
Karen Stringer |
VP, Assistant General Counsel, Deputy Chief Compliance Officer | Profile |
Kristen Galloway |
Vice President and Assistant General Counsel | Profile |
Kristen Greene |
Vice President and Assistant General Counsel | Profile |
Danielle Bello |
Counsel and Director Litigation, Risk and Claims | Profile |
Megan Isaacson |
Associate Director, Legal Operations | Profile |
Syner-G BioPharma Group is the premier solution provider of Chemistry, Manufacturing, and Controls (CMC) services for the life sciences industry. The company`s approach is based on CMC 360™, a fully integrated suite of CMC solutions that encompasses pharmaceutical development, regulatory affairs, and quality/cGxP compliance. The entire Syner-G organization is built around the premise of guiding small molecule, biologics, cell and gene therapy, and medical device innovators through the CMC process.
Integrum has since its foundation been helping amputees towards an improved quality of life. We specialize in the osseointegration method.
NOW AVAILABLETobramycin for Injections, USPOur ProductsCovid-19 Detection Kit and Extraction ReagentLearn MoreSpecialty Pharmaceutical Injectables & Ophthalmics Our ProductsIn The NewsFosun Partners with The National Children’s Cancer SocietyLearn More...
The Elixinol Group operates (or intends to operate) in the industrial hemp and medicinal cannabis industries via Elixinol USA, Elixinol AUS and Hemp Foods Australia (HFA): • Elixinol USA is an established and profitable company which manufactures and distributes industrial hemp-based CBD dietary supplements and skincare products in the United States and in forty countries globally. • Elixinol AUS is a newly formed Australian company, which has not yet commenced operations and was formed to seek the required licences and permits to participate in the emerging Australian medicinal cannabis market. • HFA manufactures and distributes industrial hemp-derived food and skincare products mainly in Australia.
A Systematic Approach To Extractables And Leachables: A Review Of Guidance From The Industry